Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0416 Ointment (Tacrolimus) in Atopic Dermatitis
NCT01053247Phase 3Completed
- Sponsor
- Fougera Pharmaceuticals Inc.
- Start
- Jan 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Fougera Pharmaceuticals Inc.. Started Jan 2008; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01053247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053247.